Novavax Inc (NVAX.O)

NVAX.O on Nasdaq

5.10USD
21 Nov 2014
Price Change (% chg)

$0.06 (+1.19%)
Prev Close
$5.04
Open
$5.12
Day's High
$5.21
Day's Low
$5.00
Volume
2,858,115
Avg. Vol
3,821,150
52-wk High
$6.95
52-wk Low
$3.17

NVAX.O

Chart for NVAX.O

About

Novavax, Inc. (Novavax) is a clinical stage biopharmaceutical company. The Company focuses on developing recombinant vaccines. The Company’s technology platform is based on recombinant vaccine technology that includes the virus-like particles (VLPs). The Company's vaccine candidates are genetically engineered three-dimensional... (more)

Overall

Beta: 1.46
Market Cap (Mil.): $1,201.93
Shares Outstanding (Mil.): 238.48
Dividend: --
Yield (%): --

Financials

  NVAX.O Industry Sector
P/E (TTM): -- 269.72 39.20
EPS (TTM): -0.30 -- --
ROI: -25.94 -1.77 17.16
ROE: -27.37 -3.18 18.09
Search Stocks

Competitors

  Price Change
Novartis AG (NOVN.VX) CHF91.95 +0.45
Merck & Co., Inc. (MRK.N) $59.66 +0.28
Sanofi SA (SASY.PA) €75.91 +0.89
GlaxoSmithKline plc (GSK.L) 1,481.50p +4.50
AstraZeneca plc (AZN.L) 4,741.00p +30.00

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: Ford Investor Services, Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks